Controlling Health Care Costs Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier? Issue Briefs / Oct 05, 2017
Controlling Health Care Costs The Case for Drug-Pricing Reform — The Cost of Inaction blog / May 26, 2021
Controlling Health Care Costs External Reference Pricing: The Drug-Pricing Reform America Needs? Issue Briefs / May 27, 2021
Controlling Health Care Costs How Federal Drug-Pricing Proposals Could Affect Medicaid blog / Aug 19, 2021
Controlling Health Care Costs Reducing Medicaid Prescription Drug Costs While Maintaining Beneficiary Access: MACPAC Recommendations for Accelerated-Approval Drugs blog / Aug 18, 2021
Achieving Universal Coverage The State of Health Insurance Coverage in the U.S. Surveys / Nov 21, 2024
Improving Health Care Quality Lawmakers Eye Lame-Duck Session for Unfinished Health Care Business Blog / Oct 29, 2024
Advancing Health Equity What’s at Stake for Latino Health in the Presidential Election Blog / Oct 28, 2024
Improving Health Care Quality Are Online Discount Websites Helping Medicare Beneficiaries? Blog / Oct 01, 2024
Controlling Health Care Costs How Do Patients and Providers Feel About Drug Costs in Medicare? Blog / Aug 06, 2024
Controlling Health Care Costs How Young Voices Can Shape Prescription Drug Policy Blog / Feb 27, 2024
Improving Health Care Quality The Forecast for Legislative and Regulatory Activity on Health Care in 2024 Blog / Jan 17, 2024
Controlling Health Care Costs How Prices for the First 10 Drugs Up for U.S. Medicare Price Negotiations Compare Internationally Publication / Jan 04, 2024
Controlling Health Care Costs How Medicare Negotiations Can Avoid Manufacturers’ Loopholes and Save Consumers Money Blog / Dec 19, 2023
Controlling Health Care Costs How Drug Price Reforms in the Inflation Reduction Act Could Impact States Blog / Nov 29, 2023
Achieving Universal Coverage Do Insurers Provide Fair Access to Prescription Drugs? It’s Complicated. Blog / Nov 03, 2023